Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04517799 · ClinicalTrials.gov registry record · Phase 2

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

A Phase 2 study of Autism Spectrum Disorder and Autism, sponsored by University of California, San Diego.

Active
Registry status
Phase 2
Development phase
42
Enrollment target
1
Study location

NCT04517799 is a Phase 2 study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 42 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04517799, a Phase 2 study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

There are very few treatments that are effective in reducing severe behavioral problems associated with autism. These behaviors include aggressive and self-harm behaviors, frequent repetitive behaviors and severe hyperactivity. This study is being conducted to determine whether cannabidiol can reduce any or all of these problem behaviors.

Conditions Studied

Autism Spectrum Disorder Autism

Interventions

  • DRUG Epidiolex
  • DRUG placebo oral solution

Study Locations (1)

California

  • University of California San Diego - La Jolla

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2020-06-01
Est. Completion 2025-12-31
Phase Phase 2

Sponsor

University of California, San Diego

775 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04517799

The ClinicalTrials.gov registry entry for NCT04517799 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (69% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Epidiolex is the first listed.

NCT04517799 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04517799 about?

NCT04517799 is a clinical study titled "Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism". There are very few treatments that are effective in reducing severe behavioral problems associated with autism. These behaviors include aggressive and self-harm behaviors, frequent repetitive behaviors and severe hyperactivity. This study is being conducted to determine whether cannabidiol can reduc...

What is the current status of trial NCT04517799?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2020-06-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04517799 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT04517799?

The interventions under investigation include: Epidiolex (DRUG), placebo oral solution (DRUG).

Who is sponsoring clinical trial NCT04517799?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04517799 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

Autism

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.